Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2008
11/20/2008US20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators
11/20/2008US20080287487 Muscle relaxants; respiratory system disorders; asthma; COPD; emphysema; bronchitis
11/20/2008US20080287467 Therapeutic Agent for Respiratory Diseases
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287416 Organic Compounds
11/20/2008US20080287405 Compositions and Methods Relating to Protein Kinase Inhibitors
11/20/2008US20080286363 (R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one maleate; 3-[(Cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide (glycopyrrolate), and a glucocorticosteroids
11/20/2008US20080286349 Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/20/2008US20080286331 Composition for an injectable bone mineral substitute material
11/20/2008US20080286270 Stabilized liquid anti-RSV antibody formulations
11/20/2008US20080286260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)
11/20/2008CA2687715A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008CA2686909A1 Pyrazolone derivatives as pde4 inhibitors
11/20/2008CA2686903A1 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
11/20/2008CA2686838A1 Modulators of cftr
11/20/2008CA2685054A1 Agent for treatment of pulmonary disease
11/20/2008CA2680344A1 Humaneered anti-factor b antibody
11/20/2008CA2667297A1 Oligoribonucleotides and uses thereof
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1991526A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
11/19/2008EP1991232A1 Combinations of steroids and methylxanthine compounds
11/19/2008EP1991202A1 Method for administration tiotropium
11/19/2008EP1641518A4 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
11/19/2008EP1513553B1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
11/19/2008EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
11/19/2008EP1448545B1 Nf-kb inhibitors
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008CN101309920A Novel method for producing tiotropium salts
11/19/2008CN101309918A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/19/2008CN101309707A Compositions comprising lipoxygenase inhibitors and cyclodextrin
11/19/2008CN101309684A Organic compounds comprising a glycopyrr onium salt
11/19/2008CN101309683A Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
11/19/2008CN101309669A Compositions of lipoxygenase inhibitors
11/19/2008CN101307051A Process for synthesizing and detecting scopolamine derivates
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306173A Decoction for treating chronic simple rhinitis
11/19/2008CN101306166A Traditional Chinese medicine orally taken for treating chronic nasal sinusitis
11/19/2008CN101306165A Decoction for treating lung impairment and cough
11/19/2008CN101306157A Traditional Chinese medicine for treating tonsillitis
11/19/2008CN101306145A Traditional Chinese medicine orally taken for treating chronic nasal sinusitis
11/19/2008CN101306139A Quality control method of Biyan Qingdu granule
11/19/2008CN101306135A Avian influenza prevention powder
11/19/2008CN101306126A Quality control method of compound south isatis root granules
11/19/2008CN101306123A Decoction for treating asthma
11/19/2008CN101306098A Chinese medicinal materials orally taken for treating bronchiectasis hemoptysis
11/19/2008CN101306090A Nasal fumigation medicaments for treating chronic simple rhinitis
11/19/2008CN101306082A Houkangsan quality control method
11/19/2008CN101306031A Chinese medicinal materials formulation for treating pneumoconiosis hemoptysis
11/19/2008CN101306029A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of Chinese angelica volatile oil, its preparation method and use
11/19/2008CN101306027A Extracting method of medical mangrove acanthus total flavonoids
11/19/2008CN101305781A Tangerine peed dumpling and its production method
11/19/2008CN100434098C Jizhi solid preparation
11/19/2008CN100434078C Ambroxol hydrochloride compound slow-release tablet and its preparing method
11/19/2008CN100433999C Throat-clearing lung-moistening fruit juice beverage and method for preparing same
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452908 Amide derivatives
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines
11/18/2008US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/18/2008US7452715 expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter; bacterial host cell transformed, transduced or transfected with the plasmid
11/18/2008US7452557 Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences
11/18/2008CA2469369C Compositions containing both sedative and non-sedative antihistamines
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2352275C Il-5 inhibiting 6-azauracil derivatives
11/18/2008CA2341366C Micronised pharmaceutical compositions
11/18/2008CA2335154C Desformoterol and process for its preparation
11/18/2008CA2333442C Spray composition
11/18/2008CA2320822C Substituted isoindolones and their use as cyclic gmp modulators in medicaments
11/18/2008CA2318184C Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative as selective endothelin antagonists
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2205112C Method and composition for treating mammalian diseases caused by inflammatory response
11/13/2008WO2008137474A1 Morphinan compounds
11/13/2008WO2008137446A1 Methods and compositions for the treatment of respiratory disease
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008135984A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
11/13/2008WO2008135819A1 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
11/13/2008WO2008135591A1 Novel benzamidine derivatives useful as potassium channel modulators
11/13/2008WO2008135557A1 Organic compounds
11/13/2008WO2008135537A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008WO2008135153A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135152A1 Novel amorphous forms of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008134817A1 Composite carriers for dry powder inhalation therapy
11/13/2008WO2008099186A8 Heterocyclic derivatives as m3 muscarinic receptors
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008US20080280986 Also prevention of pulmonary fibrosis; prodrug; sustained release form; injection, inhaled or oral form
11/13/2008US20080280974 Spiro compounds for treatment of inflammatory disorders
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 878